This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Beijing Wisdomab Biotechnology Co., Ltd., Chongqing Genrix Biopharmaceutical Co., Ltd., Beijing Wisdomab Biotechnology Co., Ltd. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
2 out of 5 
1 out of 4 Years Active: 2025-2026
Title: Xueping Zhang: Innovator in Bispecific Antibody Technology
Introduction
Xueping Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Xueping Zhang holds a patent for an innovative invention titled "ANTI-CD3 and ANTI-CD123 Bispecific Antibody and Use Thereof." This patent represents a significant advancement in the treatment of conditions that require targeted therapeutic strategies.
Career Highlights
Xueping Zhang is currently employed at Beijing Wisdomab Biotechnology Co., Ltd. His role at the company allows him to leverage his expertise in antibody technology to develop cutting-edge treatments. His dedication to research and innovation has positioned him as a key figure in the biotechnology sector.
Collaborations
Xueping collaborates with talented colleagues, including Jingjing Guo and Yulan Liu. Together, they work on various projects that aim to enhance the efficacy of bispecific antibodies and improve patient outcomes.
Conclusion
Xueping Zhang's contributions to biotechnology, particularly through his patent on bispecific antibodies, highlight his role as an innovator in the field. His work continues to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile